MSB 8.42% $1.03 mesoblast limited

Trials failed, but outcomes were very good and still applicable...

  1. 71 Posts.
    lightbulb Created with Sketch. 7
    Trials failed, but outcomes were very good and still applicable for commercialisation. There's plenty of examples where companies got declined outright and then get full approval. If you are unaware of this you're not worth discussing anything with. DYOR
    Last edited by Nikolajxo1: 02/03/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.